Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $560.30 ($4.7M) on 2026-04-02, disclosed to the SEC on 2026-04-02.
Scheduled sale ($4.7M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $560.30 | 514 | $288K | 6.1% |
| 2 | $561.69 | 351 | $197K | 4.2% |
| 3 | $562.34 | 774 | $435K | 9.3% |
| 4 | $563.58 | 371 | $209K | 4.5% |
| 5 | $564.55 | 1,115 | $629K | 13.4% |
| 6 | $565.66 | 543 |
| $307K |
| 6.5% |
| 7 | $566.66 | 1,629 | $923K | 19.7% |
| 8 | $567.55 | 1,403 | $796K | 17.0% |
| 9 | $568.79 | 690 | $392K | 8.4% |
| 10 | $569.61 | 710 | $404K | 8.6% |
| 11 | $571.61 | 200 | $114K | 2.4% |
| Total | $565.87 avg | 8,300 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |